Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Over $13 Million Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying

Published 19/12/2022, 14:01
Updated 19/12/2022, 15:10
© Reuters.  Over $13 Million Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying

Benzinga - Although US stocks closed lower on Friday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Universal Technical Institute

  • The Trade: Universal Technical Institute, Inc. (NYSE: UTI) Director Adam Gray acquired a total of 216,719 shares an average price of $6.24. To acquire these shares, it cost around $1.35 million.
  • What’s Happening: Universal Technical recently reported worse-than-expected Q4 sales results..
  • What Universal Technical Institute Does: Universal Technical Institute Inc is an educational institution. It provides undergraduate degree, as well as certificate programs for technicians in the automotive, diesel, collision repair, motorcycle and marine fields.

Global Indemnity Group

  • The Trade: Global Indemnity Group, LLC (NYSE: GBLI) Director Charles Gary Tolman acquired a total of 138,151 shares at an average price of $24.17. To acquire these shares, it cost around $3.34 million.
  • What’s Happening: The company, last month, posted better-than-expected quarterly sales.
  • What Global Indemnity Group Does: Global Indemnity Group LLC provides both admitted and non-admitted specialty property and casualty insurance coverages and individual policyholder coverages in the United States, as well as reinsurance worldwide.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Also check this: Dow Records Losses For Second Straight Week But Investor Optimism Improves

United Airlines

  • The Trade: United Airlines Holdings, Inc. (NASDAQ: UAL) Director Edward Shapiro bought a total of 25,000 shares at an average price of $39.79. To acquire these shares, it cost around $994.73 thousand.
  • What’s Happening: Goldman Sachs (NYSE:GS) reinstated United Airlines with a Buy and announced a $51 price target.
  • What United Airlines Does: United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C.

Fulcrum Therapeutics

  • The Trade: Fulcrum Therapeutics, Inc. (NASDAQ: FULC) 10% owner Rajeev Shah bought a total 2,403,049 shares at an average price of $5.44. The insider spent around $13.07 million to buy those shares.
  • What’s Happening: Fulcrum Therapeutics, last month, posted a Q3 loss of $0.51 per share.
  • What Fulcrum Therapeutics Does: Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.